Showing results 1 to 1 of 1
Issue Date | Title | Journal Title |
---|---|---|
2023 | Deep, rapid, and durable prostate-specific antigen decline with apalutamide plus androgen deprivation therapy is associated with longer survival and improved clinical outcomes in TITAN patients with metastatic castration-sensitive prostate cancer | ANNALS OF ONCOLOGY |